Picture your Future. Save for it by earning 1.5% on a 1-year Term Deposit Account! Learn more.

Notes from the Trading Desk – Franklin Templeton

Franklin Templeton’s Notes from the Trading Desk offers a weekly overview of what their professional traders and analysts are watching in the markets. The European desk is manned by eight professionals based in Edinburgh, Scotland, with an average of 15 years of experience whose job it is to monitor the markets around the world. Their views are theirs alone and are not intended to be construed as investment advice.

The Digest

European equities closed last week down 1% as the recent rotation into cyclicals/value paused for breath and saw defensives in favour. Much of the move lower came last Friday as fears of a no-deal Brexit became very real. Banks were the underperformers last week, down 6.15% on the factor rotation unwind, likely hurt further by the lack of update on the European dividend ban. There was also a more subdued economic outlook update from the European Central Bank (ECB) and their policy update was supportive in light of this, although largely in line with expectations.

Automobiles also underperformed, down 2.6%, but this comes after the sector clawed back from the March lows; it will be interesting to see if this signals a peak, or consolidation ahead of another move higher. All three major US indices were also lower, with the S&P 500 Index declining as attention focused on rising COVID-19 cases and the bi-partisan stimulus package. Equity markets in the Asia Pacific (APAC) region were mixed, with Hong Kong and mainland China the underperformers and South Korea outperforming.

Brexit Update

Another trading week finished without any Brexit resolution and a no-deal situation looking more probable. UK sterling and domestic stocks were weaker on the back of this. The domestically exposed JP Morgan ‘Brexit Basket’ closed down 5.7% on the week, whilst the FTSE 250 Index was down 2.8%. The exporter-heavy FTSE 100 Index closed last week flat. This divergence at an index level can also be seen when we look at the relationship between sterling performance and UK sectors.

Towards the end of last week, both UK Prime Minister Boris Johnson and European Commission President Ursula von der Leyen warned that a deal is looking less likely. Von der Leyen said at the European Union (EU) summit that no-deal was the most likely option, whilst Johnson also said that this outcome was ‘very, very likely’ and that the United Kingdom would ‘come out on World Trade terms’, alluding to an Australian-style relationship.

The weekend had been touted as the final deadline for deciding whether a deal would be possible. But after a call between the leaders on Sunday, it was agreed that negotiators in Brussels should continue to determine whether an agreement can actually be reached. In a joint statement, Johnson and von der Leyen said that it was ‘responsible at this point to go the extra mile’. There was no colour on how long these latest talks will continue, but the ultimate deadline is the 31 December. Time must also be allowed for both UK and EU parliaments to vote on any deal.

Markets are showing some relief that a no-deal didn’t materialize yesterday, as European equities were higher across the board and sterling clawed back Friday’s losses. The JP Morgan Brexit Basket is up 2.6% at the start of this week and there was a positive headline with comments from Michel Bernier, EU chief negotiator, that a compromise on fisheries could see a reached this week (but of course we have heard a lot of posturing like this in the past). We can clearly expect a volatile week for UK sterling and domestic stocks.

In the event of a no-deal scenario, some observers see sterling falling as much as 5% and the FTSE 250 Index could fall as much as 10%. The big UK banks could also plunge with potential for the Bank of England (BoE) to install negative interest rates. There were press reports that supermarkets have begun to stockpile basic items such as pasta, flour and tinned goods in order to support demand from the 1 January should a no-deal materialise.

Bank Dividends

There was some progress last week on the continuing pressure to end the dividend ban on UK banks. Last Thursday, the Prudential Regulation Authority (PRA) announced that UK banks were allowed to restart dividends (with caps for 2020) and buybacks. There were restrictions in place already, with distributions limited to a percentage of quarterly profits post certain adjustments and distributions. Further policy normalisation is expected post a 2021 stress test. Despite this, the UK banks were lower at the end of last week as fears over a hard Brexit dominated and as the restrictions on the dividends were digested.

There was no discussion of European bank dividends as part of last week’s ECB meeting, but the move from the United Kingdom could pressure on European authorities to do the same. This morning there were reports that European regulators are currently finalising recommendations which will permit the strongest banks to restart dividend payments. There will be certain conditions under which payments can resume, with these restrictions expected to be stricter than those enforced by the Bank of England.

The European Systemic Risk Board (ESRB) will meet on 15 December, so we can expect more clarity then. European bank stocks were higher  at the start of this week on the back of the news, but this does come following a significant underperformance last week. We think there is potential for some downside ahead, depending on just how strict the restrictions are.

Week in Review


European equities were lower across the board, with the STOXX Europe 600 Index pulling back for the first time in six weeks as the backdrop of Brexit and COVID-19 weighed on sentiment. We saw a reversal of factor rotation, which in turn saw the IBEX underperform, closing the week down more than 3%. The FTSE 100 Index fared better, down only slightly as weaker sterling supported exporters.

COVID-19 Update

Germany saw record COVID-19 numbers last Friday as the surge in cases continued. The country is now set to go into a hard lockdown starting this Wednesday until the new year. Non-essential shops will close, with workers and school children encouraged to remain at home.

In France, the number of COVID-19 patients in intensive care increased for the first time in nearly four weeks and hospitalisations also climbed by the most in three weeks. In contrast, deaths saw the smallest increase in seven weeks, but the picture still looks concerning and will put plans to enter a second phase of lockdown easing in jeopardy.

In the United Kingdom, experts in London have now said that it is inevitable that the capital will go into Tier Three in the next few days, calling the latest infection numbers ‘catastrophic’ as the rate of infection is now doubling every four days. Members of parliament that represent London boroughs and surrounding areas are set to be briefed on the latest figures today. On a positive note, the first vaccine was administered in the United Kingdom last week.


We heard from the ECB last Thursday at the conclusion of its policy meeting, and there were no major surprises, but also nothing to spook markets. The Pandemic Emergency Purchase Programme (PEPP) was boosted by €500billion (and extended to March 2022, with reinvestment to at least 2023. Preferential rates were extended to June 2022, with additional operations between June and December.

The extension of targeted longer-term refinancing operations (TLTRO) and raising of the magnitude of the facility (via an enlarged eligibility threshold) is supportive, but both were largely expected. There was also mention of ‘considerably more favourable terms’ for TLTROs, but not the rate explicitly.

The key message from the press conference was that favourable financing conditions must be preserved across all markets: banks, sovereigns and corporates (which essentially looks like yield curve control in all but name). The ECB promised to do whatever is needed to preserve monetary conditions, whether that means buying less than the envelope announced at €500 billion or adding to the total envelope. Market conditions will determine ‘whatever is needed’. The euro rose to a two-month high versus sterling last week (although sterling weakness on Brexit wobbles likely have a lot to do with the move).

On a positive note, the overhang of the EU budget impasse we have talked about recently has now been removed. Last week, leaders approved an historic US$2.2 trillion budget and stimulus package. Hungary and Poland backed down from their position, ending the ongoing dispute. Tighter emissions rules will feature as part of this budget, and on that note, environmental, social and corporate governance (ESG) had another record week, with global inflows to ESG equity funds of over US$9 billion, the highest number ever. Over past two weeks, almost 60% of global equity inflows went into ESG funds.

United States

After making fresh highs early last week, it was not too surprising to see a bit of profit taking as the S&P 500 Index drifted a little lower into the end of the week. There was plenty for investors to focus on, with ongoing negotiations of a fiscal stimulus package, COVID-19 concerns and some notable initial public offerings (IPOs).

Looking at sector performance last week, there were no dramatic moves, with energy the best-performing sector, while financials and information technology lagged. Looking at factors, value outperformed, with energy holding up well and the Russell 2000 Index finishing up 1%.

In the United States, ongoing bipartisan talks on a fiscal stimulus package were a focal point. There was a great deal of headline noise last week, but a final deal remains elusive. A bipartisan group of lawmakers is reportedly set to unveil a US$908 billion coronavirus pandemic relief bill this week, although there’s no guarantee Congress will pass it

Last week saw a couple of notable IPOs, with both Doordash and Airbnb seeing remarkable debuts. Doordash gained 85% on its first day and Airbnb 113%. These debuts are reminiscent of the technology debuts during the dotcom era. There has been speculation as to how much retail demand drove these moves, given the boom in that space this year. It has been a record year for capital markets, with US$149 billion raised through IPOs in the United States this year.

Last week the Food and Drug Administration (FDA) approved the Pfizer COVID-19 vaccine, which was a much-needed positive in a week that saw numbers of new cases and deaths continue to trend higher. The daily death toll has been rising sharply, with daily deaths over 3,000 on some days last week.

We did see some interesting research this weekend highlighting that a growing number of US citizens would agree to be vaccinated, which is encouraging for the rollout of the vaccination programme.

Asia Pacific

Last week saw a mixed performance for Asian markets, with South Korea outperforming, Australia essentially flat on the week, and Japan, Hong Kong and Shanghai markets down.

South Korean equities continued their march higher, with the benchmark KOSPI now +90% from COVID-19 lows and +25% year-to date, as the economy continues its impressive recovery, led higher by technology heavyweights such as Samsung. South Korea’s nimble reaction to the COVID-19 crisis and the subsequent recovery is a stark contrast to the embattled European economies.

In China, there is a renewed focus on technology monopolies. Chinese equities did lag last week, but they have also done well post-COVID-19, with the MSCI China Index closing at all-time highs.

Elsewhere in the region, Hong Kong Chief Executive Carrie Lam announced that the city will return to tightest virus restrictions as cases spike.

Finally, there was encouraging data from China as freight rates reached new heights in December. This is encouraging and implies that the strong export performance seen the previous month will continue. (We would note that demand for shipping containers has surged recently.)

Week Ahead

Focus will remain on any read-through from any of our key themes from this week.

Monday 14 December:

Data: Eurozone industrial production

Tuesday 15 December:

Data: UK unemployment rate; France Consumer Prices Index (CPI); Italy CPI, trade balance

Wednesday 16 December:

Data: UK CPI and Retail Prices Index (RPI); Italy industrial sales; Eurozone trade balance and labour costs

Thursday 17 December:

Data: Eurozone car registrations, CPI; France manufacturing confidence; Spain labour costs

Monetary: Bank of England policy meeting

Friday 18 December:

Data: UK consumer confidence; Germany PPI; Spain trade balance; Italy PPI


Franklin Templeton Key risks & Disclaimers:

What Are the Risks?

All investments involve risk, including possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested. Stock prices fluctuate, sometimes rapidly and dramatically, due to factors affecting individual companies, particular industries or sectors, or general market conditions. Bond prices generally move in the opposite direction of interest rates. Thus, as prices of bonds in an investment portfolio adjust to a rise in interest rates, the value of the portfolio may decline. Investments in foreign securities involve special risks including currency fluctuations, economic instability and political developments. Investments in developing markets involve heightened risks related to the same factors, in addition to those associated with their relatively small size and lesser liquidity. Past performance is not an indicator or guarantee of future performance.

This article reflects the analysis and opinions of Franklin Templeton’s European Trading Desk as of 15th December 2020, and may vary from the analysis and opinions of other investment teams, platforms, portfolio managers or strategies at Franklin Templeton. Because market and economic conditions are often subject to rapid change, the analysis and opinions provided may change without notice. An assessment of a particular country, market, region, security, investment or strategy is not intended as an investment recommendation, nor does it constitute investment advice. Statements of fact are from sources considered reliable, but no representation or warranty is made as to their completeness or accuracy. This article does not provide a complete analysis of every material fact regarding any country, region, market, industry or security. Nothing in this document may be relied upon as investment advice or an investment recommendation. The companies named herein are used solely for illustrative purposes; any investment may or may not be currently held by any portfolio advised by Franklin Templeton. Data from third-party sources may have been used in the preparation of this material and Franklin Templeton (“FT”) has not independently verified, validated or audited such data. FT accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments, opinions and analyses in the material is at the sole discretion of the user. Products, services and information may not be available in all jurisdictions and are offered by FT affiliates and/or their distributors as local laws and regulations permit. Please consult your own professional adviser for further information on availability of products and services in your jurisdiction. 

Issued by Franklin Templeton Investment Management Limited (FTIML) Registered office: Cannon Place, 78 Cannon Street, London EC4N 6HL. FTIML is authorised and regulated by the Financial Conduct Authority.

MeDirect Disclaimers:

This information has been accurately reproduced, as received from Franklin Templeton Investment Management Limited (FTIML). No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment and may be deducted from the invested amount therefore lowering the size of your investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Investor Information Document (KIID), which may be obtained from MeDirect Bank (Malta) plc.

Join MeDirect today to access the tools you need to put your money to work on your own terms.

Latest news articles

Staying dynamic in our strategic views
All News

BlackRock Commentary: Staying dynamic in our strategic views

BlackRock anticipates that the new macroeconomic environment, characterized by increased volatility, will lead to more frequent valuation changes across asset classes. While short-term outcomes may not always be influenced by valuations, they remain significant in the long run.

Experience better Banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. 

Sign up and open your account for free, within minutes.



We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.